Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody

Intern Med. 2002 Jul;41(7):584-8. doi: 10.2169/internalmedicine.41.584.


It has been reported that there is a subgroup of dermatomyositis (DM) patients with rapidly progressive interstitial lung disease (ILD) who have mild muscle symptoms, slightly increased levels of muscle enzymes, and absence of anti-Jo-1 antibody. A 51-year-old woman with DM was intubated requiring mechanical ventilation because of a rapidly progressing ILD in spite of the absence of the typical poor prognostic factors. A high dose or pulse therapy of corticosteroids was not effective, but additional treatment of cyclosporine gradually improved her respiratory condition. It is not clear why a rapidly progressive ILD occurred in this case lacking poor prognostic factors. However, if corticosteroid treatment is not effective, additional administration of cyclosporine in the early period of rapidly progressive ILD may rescue deteriorating cases.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / immunology*
  • Creatine Kinase / blood*
  • Cyclosporine / therapeutic use
  • Dermatomyositis / complications
  • Dermatomyositis / diagnosis
  • Dermatomyositis / immunology*
  • Disease Progression
  • Female
  • Histidine-tRNA Ligase / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lung Diseases, Interstitial / complications
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / immunology*
  • Middle Aged
  • Muscular Diseases / complications*
  • Prognosis
  • Steroids
  • Tomography, X-Ray Computed
  • Treatment Outcome


  • Anti-Inflammatory Agents
  • Autoantibodies
  • Immunosuppressive Agents
  • Steroids
  • Cyclosporine
  • Creatine Kinase
  • Histidine-tRNA Ligase